| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |